Turn Therapeutics Inc. (TTRX) stock
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$8.55−0.79 (-8.51%)
Close on Nov 16, 2026Market cap $254.69MP/E –Yield –
Turn Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Turn Therapeutics
Turn Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?